Put ** EYCCF ** On Your Watchlist!

?awt_a=1jS4A&awt_l=Dx3Vy&awt_m=iROcEurL8wvde4A Today's Alert Is: EYCCF EYCCF could become the go to visual training company for professional and college sports teams all over! Greetings All, EYCCF could be one of the most exciting companies to be trading under the radar right now! With a tiny float and a breakout from under 10 cents to over 50 cents not too long ago, the stock could be gearing up for a big bounce. We've seen a volatile market amid the coronavirus pandemic with a massive sell off plunging the markets. EYCCF is a tech stock that could come back roaring if more of Wall Street discovers the company. Especially as they are focusing on a niche category that nobody is really talking about yet could be a very lucrative opportunity! Did you know that 1 in 4 people worldwide are living with issues related to their vision that go beyond visual acuity? Despite this, ophthalmic treatment primarily focuses on visual acuity issues and disease management, leaving many visual performance issues undiagnosed or mistreated. Standard eye exams DO NOT cover reaction time, peripheral vision or depth perception! The vision for EYCCF originally was to fix the visual system, the muscles of the eye. The company then rebuilt hardware, commercialized their technology and redirected their focus to high performance athletics in a number of sports. This is the human performance world and EYCCF could become a leading player in it! Binovi is the trademark of the company and built the brand around developing a binocular system which combines the brain, body, and visual system. EYCCF is not constrained by distribution problems due to COVID-19 and does not anticipate delivery problems of the product. This is a big plus for the company during these uncertain times! Moving towards high performance for the athletic market was a pretty brilliant move considering that sports teams across the nation spend millions of training. The Los Angeles Lakers spent nearly $100 million to make their new training facility a few years back. The market is immense when you consider pro teams, collegiate teams, the NCCA. It is a huge market for performance and EYCCF is here to help. We all root for the guy who hits the home run or scores the big goals. These players rely heavily on their eyes to make such moves. Sports Vision Training is how the company can help tailor the visual system, and those that rely on it, to improve performance in athletes across all sports, and all positions. Sports teams and high-performance athletic training organizations are realizing the benefit of neurovision training to augment their physical training regimen. With the current COVID-19 pandemic and the isolation measures being taken to minimize exposure to coronavirus, athletes are looking to hone their skill set, including the gained performance advantages of neurovision training. This has led to a heightened level of interest in the Binovi Touch Platform! A purposeful and powerful tool for vision therapy and vision training, the Binovi Touch is the result of over 30 years of experience in over 1,500 practices in over 20 countries around the world on children, athletes, and seniors resolving issues from development, to performance, to rehabilitation. The Binovi Touch was designed to be as versatile as possible. Portable - built for endurance, yet light enough for you to carry. Universal - powered via USB so it is easy to use, wherever you are in the world. Expandable - the Binovi Touch is modular. Control multiple Binovi Touch devices from the app at the same time to increase the range and difficulty of activities and link other Binovi and 3rd Party devices. Many sports optometrists believe that the eyes lead the body. Vision allows the athlete to determine the when and where (i.e. the time and place, an action should be performed). While much of the research in sports in the last few decades has focused on nutrition and bio-mechanics, the work has been done largely without changes to the visual system, leaving potential performance improvements on the table for these athletes. Enhancing visual performance can help improve overall performance in ways other training regiments cannot. The Binovi Touch is designed to help improve visual performance-such as increasing visual memory, decreasing reaction times, and improving eye-hand coordination, and visual perception is an integral component to improving overall performance. The high-speed, high-impact play of NHL-level hockey is the perfect example of a sport in which improved human performance can have a huge impact. EYCCF has a multi-year partnership with Eli Wilson Goaltending, a world leader in goaltending development, goaltending camps, and clinics! Eli Wilson has established himself as one of the premier goaltending coaches in the world through his work with dozens of goaltenders in the National Hockey League (NHL) and Team Canada. The partnership will provide Eli Wilson Goaltending camps with the Binovi Touch neurovision sports training hardware, alongside screen-based resources for athletes to support their development on and off the ice. The Eli Wilson Goaltending partnership will ultimately expose 600 active goaltending camp participants, aged 10 to 19 years and a global network of over 50,000 aspiring goaltending athletes to Eyecarrot's Binovi Sport Vision Platform for off-ice training. Under his tutelage, Eli's camps which see over 600 athletes annually have produced more than 50 NHL draft picks, over 60 Division I, Canadian University goaltenders, and more than 200 players drafted by Major Junior teams. EYCCF CEO Adam Cegielski commented, "Were very excited to be working with an athletic training team that clearly has a very high drive for success, and such an incredible track record for turning out exceptional players. Our goal is to see Binovi boost the performance of athletes going through these camps and training regimens. After all, competition is what drives sport, and any edge players and their training teams can get to get that competitive edge over an opponent is key. We look forward to working alongside Eli and his team as we continue to develop Binovi for sports." EYCCF also has a new vision training partnership with the Dallas Stars of the National Hockey League (NHL). This partnership will utilize Binovi Vision Training Technology, engineered by Eyecarrot, in conjunction with the expert instruction of Dr. Charles Shidlofsky, a leader in sports vision and neuro-vision training. This could be just the beginning for more partnerships for the company! With a tiny trading float, any positive news could serve as a catalyst for share prices jumping. Keep an eye out! Hurry and do your own due diligence at: [www.eyecarrot.com]( and [( EYCCF has seen gains of over 100% before and could soon do it again! GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER. We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of DearWallstreet.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisers, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on DearWallstreet.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. DearWallstreet.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. DearWallstreet.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@DearWallstreet.com. Some of the content on this website contains forward-looking information within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of a company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward looking statements or announcements mentioned on this website or the websites contained within. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results. Generally, the information regarding a company profiled or discussed on this website is provided from public sources. DearWallstreet.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained through our website or in communications originating from our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and DearWallstreet.com has no obligation to update any of the information provided. DearWallstreet.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions. From time to time certain content on this website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled on this website may not have approved certain or any statements within the website. DearWallstreet.com encourages viewers to supplement the information obtained from this website with independent research and other professional advice. The content on this website is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Third Party Web Sites and Other Information This website may provide hyperlinks to third party websites or access to third party content. DearWallstreet.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does DearWallstreet.com control, endorse, or guarantee any content found in such sites. DearWallstreet.com does not control, endorse, or guarantee content found in such sites. By accessing, viewing, or using the website or communications originating from the website, you agree that DearWallstreet.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that DearWallstreet.com, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. DearWallstreet.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the United States Securities and Exchange Commission (SEC). The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or the Financial Industry Regulatory Authority (FINRA) at: www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/Investors/index.htm. Income Disclaimer: Testimonials and examples used here are exceptional results which may not apply to the average purchaser. They are not intended to represent or guarantee that anyone will achieve the same or similar results through our service. The use of our information should be based on your own due diligence, and you agree that our company is not liable for any success or failure of your business that is directly or indirectly related to the use of our information. As with any business, your results may vary, and will be based on your individual capacity, business experience and expertise. There are no guarantees concerning the level of success you may experience. Income statements made by our customers are only estimates of what they have earned; there is no guarantee that you will make these levels of income. When using our information you accept the risk that these earnings and income statements differ by individual. There is no assurance that examples of past earnings can be duplicated in the future. There are unknown risks in business and on the internet that we cannot anticipate which can reduce results. We therefore cannot guarantee your future results or success, and are not responsible for your actions. DearWallstreet.com has been paid up to $100,000 in cash compensation from Eyecarrot Innovations for this profile of Eyecarrot Innovations (OTC: EYCCF) which services include the issuance of this release and other opinions that we release concerning of Eyecarrot Innovations (OTC: EYCCF) DearWallstreet.com has not investigated the background of Eyecarrot Innovations, the hiring party, or Eyecarrot Innovations (OTC: EYCCF) Anyone viewing this newsletter should assume Eyecarrot Innovations or affiliates of Eyecarrot Innovations, own shares of the Eyecarrot Innovations (OTC: EYCCF) which they plan to liquidate, and further understand that the liquidation of those shares may or may not negatively impact the share price.DearWallstreet.com has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements regarding Eyecarrot Innovations (OTC: EYCCF) Rua Frei Tomé de Jesus n. 18 1 dto. Lisboa Lisboa 1700-215 PORTUGAL [Unsubscribe]( | [Change Subscriber Options](